|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
07.21 |
|
|
(ÁÖ)Á¦À̾¾¹ÙÀÌ¿À |
Standard Biotools ÇмúÁö¿ø&±â¼ú¿µ¾÷¸¶ÄÉÆà ä¿ë
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
01.04 |
|
|
(ÁÖ)¿À·¡¿Â¶óÀÌÇÁ»çÀ̾𽺠|
[¸ÞµðÄà ¿¡½ºÅ×ƽ] ÇØ¿Ü¿µ¾÷ °æ·Â ä¿ë
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
¹«¿ª/ÇØ¿Ü¿µ¾÷/Åë¹ø¿ª |
3³â¡è |
ä¿ë½Ã |
04.30 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
03.19 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CRA I/II
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
1³â¡è |
ä¿ë½Ã |
03.19 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Feasibility - Site ID Specialist
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
SSU |
2³â¡è |
ä¿ë½Ã |
07.21 |
|
|
PSI CRO Korea |
[PSI CRO Korea] CTA I/II, Sr.CTA
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CTA/CRC |
1³â¡è |
ä¿ë½Ã |
07.21 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Senior CRA I/II (Lead Monitor Role)
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
CRA/ÀÓ»óPM/CRM |
5³â¡è |
ä¿ë½Ã |
07.21 |
|
|
PSI CRO Korea |
[PSI CRO Korea] Regulatory Officer / Senior Regulatory O
¼¿ï ¼ÛÆı¸ | Çз¹«°ü |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
05.04 |
|
|
µ§Ã÷ÇöóÀ̽÷γªÄÚ¸®¾Æ |
[¿Ü±¹°è ÀÇ·á±â±â] QA Administrator(»êÈÞ ´ëü)
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
Ç°Áú°ü¸®/Ç°Áúº¸Áõ |
1³â¡è |
ä¿ë½Ã |
08.03 |
|
|
ÁÖ½Äȸ»ç ¿¡½º¿¥¿¤Á¦´ÏÆ®¸® |
[SMLÁ¦´ÏÆ®¸®] RA(ÆÀÀå±Þ) °æ·ÂÁ÷ ¼ö½Ã ä¿ë °ø°í
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
5³â¡è |
ä¿ë½Ã |
09.07 |
|
|
µ§Ã÷ÇöóÀ̽÷γª |
[¿Ü±¹°è ÀÇ·á±â±â] RA/QA Specialist
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
°³¹ß/RA/´ë°ü |
1³â¡è |
ä¿ë½Ã |
05.31 |
|
|
(ÁÖ)Á¦À̾¾¹ÙÀÌ¿À |
¹ÙÀÌ¿À °ü·Ã Á¦Ç° ¿µ¾÷(Àåºñ ¹× ½Ã¾à) Á÷¿ø ä¿ë
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(4³â) Á¹¾÷ |
»ý¸í°øÇÐ/¹ÙÀÌ¿À ¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
04.29 |
|
|
³ëº¸³ëµð½ºÅ©Á¦¾à(ÁÖ) |
[±Û·Î¹ú Á¦¾à»ç] Medical Advisor ä¿ë
¼¿ï ¼ÛÆı¸ | ´ëÇпø(¼®»ç) Á¹¾÷ |
¿¬±¸/¿¬±¸±âȹ |
5³â¡è |
ä¿ë½Ã |
04.29 |
|
|
(ÁÖ)¿¡ÇÁ¾Øµð³Ý |
¿¡ÇÁ¾Øµð³Ý º»»ç °Ç°±â´É½ÄÇ° º´¿ø/¾à±¹ ¿µ¾÷»ç¿ø ä¿ë
¼¿ï ¼ÛÆı¸ | ´ëÇÐ(2~3³â) Á¹¾÷ |
°Ç°º¸Á¶½ÄÇ°/ÈÀåÇ°¿µ¾÷ |
°æ·Â¹«°ü |
ä¿ë½Ã |
|
|